Herantis Pharma to participate in Biotech Showcase and Sachs virtual conferences
Herantis Pharma Plc, Press Release, 4 January 2023 at 09:00 A.M. EET Herantis Pharma Plc (“Herantis”), developing disease modifying therapies for Parkinson’s disease, today announced that the management team will have meetings with potential investors and partners at: Sachs 6[th] Annual Neuroscience Innovation Forum (Virtual) Dates: January 16[th]-20[th], 2023 Biotech Showcase (Virtual) Dates: January 18[th]-19[th], 2023 CEO, Antti Vuolanto will hold a virtual Company presentation: Date: Tuesday, January 10, 2023 Time: 10:30AM (PST) Track: Yosemite A (Ballroom